Gastroenterology - European Medical Journal

This site is intended for healthcare professionals

Continue

Gastroenterology

Filter
22 Jun 2016

IBD Drug Availability Putting Children at Risk of Lifelong Health Complications

June 21, 2016 – To halt the health risks for children and improve outcomes in the future, IBD experts across Europe are calling for an urgent increase in…
31 May 2016

Children’s Digestive Health Across Europe in Crisis

Brussels, 31 May, 2016: A report investigating the current state of digestive health in children has revealed alarming trends in disease incidence and…
25 May 2016

New Phase 3 Study Findings Show STELARA® Maintained Clinical Remission after One Year of Treatment in Patients with Moderate to Severe Crohn’s Disease

SAN DIEGO, May 23, 2016: Janssen Research & Development, LLC (Janssen) Phase 3 data presented for the first time at Digestive Disease Week® 2016 showed…
EMJ
4 Apr 2016

Mirtazapine: A New Treatment for Functional Dyspepsia

IMPROVEMENTS in many symptoms of functional dyspepsia have been observed in a pilot study of mirtazapine, an antidepressant.
EMJ
4 Apr 2016

Aspirin: A Potential Preventative Treatment for Colorectal Cancer

A NOVEL use for aspirin has recently been discovered in two long-term studies. Whilst aspirin is commonly used to treat or prevent cardiovascular disease…
EMJ
31 Mar 2016

Medics Call for Urgent Improvements in the Quality of Endoscopy across Europe

Vienna, March 30, 2016: Every year, tens of millions of individuals across Europe undergo endoscopic procedures to assist with the diagnosis and…
EMJ
11 Mar 2016

Gut Profiling: New Biomarkers for Metabolic Diseases

March 11, 2016: For diagnosing or predicting metabolic diseases such as obesity, insulin resistance or type two diabetes (T2D), doctors commonly make use…
EMJ
19 Feb 2016

Norgine Launches XIFAXAN® 200mg (aifaximin-α) for the Treatment of Travellers Diarrhoea in Australia

LONDON, UK, Friday 19 February, 12:00 GMT: Norgine B.V. has today announced that XIFAXAN® 200mg is now available in Australia for the treatment of…
We’ve noticed you’re accessing
from North/South America.